Is high-dose chemotherapy and stem cell transplantation an option?
Patients who respond or obtain stable disease after treatment for relapsed or refractory myeloma may be eligible to undergo high-dose chemotherapy and stem cell transplantation. In addition, a second stem cell transplant is sometimes performed in patients who have relapsed after an initial stem cell transplant. In order to be a candidate for stem cell transplant, you should be in generally good health, although some patients with kidney failure have been able to undergo transplant using lower doses of chemotherapy. However, if you have previously received certain types of myeloma treatment (such as melphalan or radiation to the pelvic area) you may not be able to undergo transplantation. Learn more about high-dose chemotherapy and stem cell transplantation.
